March 24, 2020 / 11:58 AM / 7 days ago

FACTBOX-Global pharma industry steps up efforts to battle coronavirus

 (Adds Abbott, Biomerica, Sugentech, PerkinElmer; updates J&J, Inovio, Qiagen, Gilead)
    March 31 (Reuters) - Drugmakers across the globe are rushing to develop a treatment or vaccine for the fast-spreading coronavirus that has wreaked havoc across the
globe, killing over 38,800 people and ravaging financial markets.
    Along with medical researchers and public health authorities, diagnostic test makers are also launching their own test kits to expand testing.
    While testing of vaccines in humans began earlier this month, experts say it could take a year or more to have a vaccine ready. 
 Date of    Company                                      Progress                                                                                Story link
 March 31   Qiagen NV                                    The German company has launched a test in Europe that may detect coronavirus in about               
                                                         an hour. The test is also allowed for use in the United States.                         
 March 27   Abbott Laboratories                          The company plans to produce 5 million tests per month, which includes one testing                  
                                                         platform that can deliver results in minutes.                                           
 March 21   Danaher Corp                                 Company's Cepheid unit has gained U.S. approval for a rapid diagnostic test that can                
                                                         detect the coronavirus in about 45 minutes.                                             
 March 22   Roche Holding AG                             The U.S. has authorized a test made by the Swiss pharma company that can provide                    
                                                         results in 3-1/2 hours and can produce up to 4,128 results daily. The test is also      
                                                         available for countries that accept the "CE" mark.                                      
 March 20   Co-Diagnostics                               The FDA has allowed widespread distribution of its tests to U.S. labs.                              
 March 23   Laboratory Corp of America Holdings          Its coronavirus tests are available for ordering by healthcare providers. It is to be               
                                                         used in patients who meet the current guidance for testing.                             
 March 5    Quest Diagnostics Inc                        Laboratory company has already rolled out a test service for the coronavirus.                       
 March 16   Hologic Inc                                  Emergency use of its diagnostic kit, which is able to process up to 1,000 tests in 24               
                                                         hours, is permitted in United States.                                                   
 March 17   OPKO Health                                  Company's diagnostics unit has tied up with the New York State Department of Health to              
                                                         provide drive-through facility on the East Coast to test COVID-19 and expects to begin  
                                                         offering up to 5,000 tests a day at additional satellite testing sites.                 
 March 27   Sugentech Inc                                The South Korean company has started selling a blood test outside the United States.                
 March 25   Biomerica Inc                                Has received orders for its blood test from Europe and Middle East.                                 
 March 24   PerkinElmer Inc                              Emergency use of its coronavirus test allowed in the United States, and the device is              
                                                         available in over 30 countries worldwide.                                               
 Date of   Company name                              Progress                                                                                 Story link 
 March 30  Moderna Inc                               A patient was dosed with the company's vaccine on March 16 in an early-stage trial. Has              
                                                     also signed a deal with the U.S. government to produce massive quantities of its         
 March 17  BioNTech SE                               The German drugmaker is working with Pfizer Inc         to develop a vaccine that uses               
                                                     synthetic messenger RNA to inoculate against the virus.                                  
 March 24  Inovio Pharma                             The U.S.-based drug developer plans to conduct human trials of its vaccine in April.                 
 March 30  Johnson & Johnson                         Signed a $1 billion deal with the U.S. to create more than 1 billion doses of a                      
                                                     vaccine. The pharma giant plans to test the vaccine in humans by September.              
 Date of  Company name                              Progress                                                                                                     Story link 
 March    Gilead Sciences Inc                       Company's remdesivir is an antiviral that is being tested in patients with severe and moderate cases of the              
 25                                                 illness. The company has asked the U.S. to take back a controversial "orphan drug" status granted to it      
                                                    last week.                                                                                                   
 March                                              Has expanded the testing of its rheumatoid arthritis drug, Kevzara, with partner Sanofi          .                       
 30       Regeneron Pharmaceuticals Inc             Regeneron has also identified hundreds of antibodies that could treat or prevent the coronavirus and was     
                                                    preparing to begin clinical trials by early summer.                                                          
 March                                              China approved the use of the company's anti-inflammation drug Actemra in patients who develop severe                    
 23       Roche                                     complications from the coronavirus. Has received U.S. clearance to test the drug in coronavirus, but the     
                                                    company has not disclosed when it expects to start U.S. trials.                                              
 March 5  BioCryst Pharmaceuticals Inc              Its treatment, galidesivir, works by interfering with a virus' ability to replicate. The antiviral has                   
                                                    shown promise in a range of viruses and proven to be safe in healthy volunteers.                             
 March    Eli Lilly Co                              The U.S. drugmaker has said it would co-develop antibody products for the treatment and prevention of                    
 12                                                 COVID-19 with AbCellera Biologics; goal is to start human testing within the next four months.               
 March    AbbVie Inc                                Israel has approved a generic version of the company's branded HIV drug Kaletra. AbbVie has donated the                  
 19                                                 drug to China to test its use in coronavirus patients.                                                       
 Mylan NV, Teva Pharmaceutical Industries and Amneal Pharmaceuticals Inc are ramping up production of their own versions of malaria drug
hydroxychloroquine, which is being tested in multiple clinical trials against the coronavirus. Novartis and Bayer AG have said they will donate their own
versions of that drug. 

 (Reporting by Manas Mishra and Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila and Arun Koyyur)
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below